How to get treated for long COVID in NY and NJ

June 20, 2022

Long COVID is a bummer. Even mild infections of the coronavirus are leading to weeks and months of lingering symptoms such as loss of smell, confusion due to mental brain fog, and fatigue.

But severe outcomes, such as heart disorders and kidney disease, are appearing, sometimes well after people have recovered. Vaccines appear to waylay some of the ill effects, but large-scale studies are finding in inoculated people with “post-acute sequelae of SARS-CoV-2 infection” or PASC.

**************

“Insurance companies will sometimes disallow certain costs as not medically necessary, particularly in situations where there is that kind of gray area about medical necessity,” said Joel Cantor, director of the Center for State Health Policy at Rutgers University, told Gothamist. “That’s an ongoing challenge, particularly for folks who have multiple symptoms.”

Medical necessity is initially judged by a person’s physician, and doctors need to document the conditions correctly in order for patients to receive insurance coverage.

Gothamist, June 19, 2022

Recent Posts

Heldrich: Aligning NJ’s AI Policy with Small Business Needs

Researchers at the Heldrich Center for Workforce Development, with funding from the New Jersey State Policy Lab, are currently engaged in a project to examine how New Jersey’s public Artificial Intelligence (AI) initiatives can better align with the evolving needs of...

EJB Talks: Planning, Policy, Politics, and the Path to Office

Planning, Policy, Politics, and the Path to Office with Assemblywoman Katie Brennan This week on EJB talks, Dean Stuart Shapiro talks to Bloustein alumnus Katie Brennan MCRP '12, now an Assemblywoman in New Jersey's 32nd District. Katie reflects on how her early...

Report Release: R/ECON Forecast Winter 2026

Read Report R/ECON’s economic forecast for New Jersey at the beginning of 2026 is a mixed bag. The state, like the nation, is likely to finish the year with notably stronger GDP growth than forecast earlier in the year. At the same time, the outlook for 2026 continues...